Abstract
From July 2007 to June 2009, all pneumococci causing invasive pneumococcal disease in our hospital were serotyped. Antimicrobial susceptibility was determined by microdilution. Molecular typing was performed by pulsed-field gel electrophoresis and by multilocus sequence typing. Among 251 invasive pneumococci, serotype 8 was the most frequent (13.5%). All serotype 8 strains were susceptible to penicillin; however, 61.8% (21/34) were co-resistant to erythromycin, levofloxacin and tetracycline and identical to the Sweden15A-ST63 clone. Serotype 8 was significantly more frequent among human immunodeficiency virus (HIV)-infected patients (36.5%). The high prevalence of this non-conjugate vaccine multiresistant serotype 8 is a cause for concern mainly in HIV-infected patients. © 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.
Author supplied keywords
Cite
CITATION STYLE
Sanz, J. C., Cercenado, E., Marín, M., Ramos, B., Ardanuy, C., Rodríguez-Avial, I., & Bouza, E. (2011). Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV+ patients. Clinical Microbiology and Infection, 17(7), 1094–1098. https://doi.org/10.1111/j.1469-0691.2011.03495.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.